nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Methotrexate—psoriasis	0.068	0.0998	CbGbCtD
Perphenazine—CYP2C8—Tazarotene—psoriasis	0.0667	0.0978	CbGbCtD
Perphenazine—CYP1A2—Clobetasol propionate—psoriasis	0.0633	0.0928	CbGbCtD
Perphenazine—CYP2B6—Cholecalciferol—psoriasis	0.0376	0.0551	CbGbCtD
Perphenazine—CYP1A2—Methoxsalen—psoriasis	0.0333	0.0488	CbGbCtD
Perphenazine—CYP2D6—Hydroxyurea—psoriasis	0.03	0.0439	CbGbCtD
Perphenazine—CYP2C8—Cholecalciferol—psoriasis	0.0285	0.0417	CbGbCtD
Perphenazine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0247	0.0362	CbGbCtD
Perphenazine—CYP2C19—Cholecalciferol—psoriasis	0.0239	0.035	CbGbCtD
Perphenazine—CYP3A4—Calcitriol—psoriasis	0.0224	0.0329	CbGbCtD
Perphenazine—CYP2C9—Cholecalciferol—psoriasis	0.0198	0.0291	CbGbCtD
Perphenazine—CYP2C8—Hydrocortisone—psoriasis	0.0198	0.029	CbGbCtD
Perphenazine—CYP2C8—Cyclosporine—psoriasis	0.0187	0.0274	CbGbCtD
Perphenazine—CYP2D6—Cholecalciferol—psoriasis	0.0182	0.0266	CbGbCtD
Perphenazine—CYP3A4—Methoxsalen—psoriasis	0.0174	0.0256	CbGbCtD
Perphenazine—CYP2C19—Prednisone—psoriasis	0.0165	0.0243	CbGbCtD
Perphenazine—CYP2B6—Dexamethasone—psoriasis	0.0163	0.0238	CbGbCtD
Perphenazine—CYP2C19—Cyclosporine—psoriasis	0.0157	0.023	CbGbCtD
Perphenazine—CYP2C9—Cyclosporine—psoriasis	0.013	0.0191	CbGbCtD
Perphenazine—CYP2C8—Dexamethasone—psoriasis	0.0123	0.0181	CbGbCtD
Perphenazine—CYP2D6—Cyclosporine—psoriasis	0.0119	0.0175	CbGbCtD
Perphenazine—CYP3A4—Cholecalciferol—psoriasis	0.0115	0.0169	CbGbCtD
Perphenazine—CYP2C19—Dexamethasone—psoriasis	0.0103	0.0151	CbGbCtD
Perphenazine—CYP3A4—Mycophenolate mofetil—psoriasis	0.01	0.0147	CbGbCtD
Perphenazine—CYP3A4—Triamcinolone—psoriasis	0.01	0.0147	CbGbCtD
Perphenazine—CYP2C9—Dexamethasone—psoriasis	0.00859	0.0126	CbGbCtD
Perphenazine—CYP3A4—Betamethasone—psoriasis	0.00859	0.0126	CbGbCtD
Perphenazine—CYP3A4—Prednisolone—psoriasis	0.00847	0.0124	CbGbCtD
Perphenazine—CYP3A4—Hydrocortisone—psoriasis	0.00803	0.0118	CbGbCtD
Perphenazine—CYP3A4—Prednisone—psoriasis	0.008	0.0117	CbGbCtD
Perphenazine—CYP2D6—Dexamethasone—psoriasis	0.00785	0.0115	CbGbCtD
Perphenazine—CYP3A4—Cyclosporine—psoriasis	0.00758	0.0111	CbGbCtD
Perphenazine—CYP3A4—Dexamethasone—psoriasis	0.00499	0.00732	CbGbCtD
Perphenazine—Bradycardia—Hydrocortisone—psoriasis	0.000264	0.00121	CcSEcCtD
Perphenazine—Pain—Hydroxyurea—psoriasis	0.000261	0.0012	CcSEcCtD
Perphenazine—Constipation—Hydroxyurea—psoriasis	0.000261	0.0012	CcSEcCtD
Perphenazine—Dry mouth—Mycophenolic acid—psoriasis	0.000261	0.0012	CcSEcCtD
Perphenazine—Confusional state—Mycophenolic acid—psoriasis	0.000258	0.00118	CcSEcCtD
Perphenazine—Dizziness—Acitretin—psoriasis	0.000258	0.00118	CcSEcCtD
Perphenazine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000257	0.00118	CcSEcCtD
Perphenazine—Infection—Mycophenolic acid—psoriasis	0.000254	0.00117	CcSEcCtD
Perphenazine—Shock—Mycophenolic acid—psoriasis	0.000252	0.00116	CcSEcCtD
Perphenazine—Tachycardia—Mycophenolic acid—psoriasis	0.00025	0.00115	CcSEcCtD
Perphenazine—Hyperglycaemia—Dexamethasone—psoriasis	0.00025	0.00115	CcSEcCtD
Perphenazine—Hyperglycaemia—Betamethasone—psoriasis	0.00025	0.00115	CcSEcCtD
Perphenazine—Bradycardia—Triamcinolone—psoriasis	0.000248	0.00114	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—psoriasis	0.000247	0.00113	CcSEcCtD
Perphenazine—Muscular weakness—Prednisone—psoriasis	0.000246	0.00113	CcSEcCtD
Perphenazine—Anorexia—Mycophenolic acid—psoriasis	0.000244	0.00112	CcSEcCtD
Perphenazine—Muscle spasms—Cyclosporine—psoriasis	0.000244	0.00112	CcSEcCtD
Perphenazine—Headache—Acitretin—psoriasis	0.000244	0.00112	CcSEcCtD
Perphenazine—Headache—Fluocinolone Acetonide—psoriasis	0.000243	0.00112	CcSEcCtD
Perphenazine—Body temperature increased—Hydroxyurea—psoriasis	0.000242	0.00111	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—psoriasis	0.000241	0.0011	CcSEcCtD
Perphenazine—Hypotension—Mycophenolic acid—psoriasis	0.000239	0.0011	CcSEcCtD
Perphenazine—Vision blurred—Cyclosporine—psoriasis	0.000239	0.0011	CcSEcCtD
Perphenazine—Muscle spasms—Mycophenolate mofetil—psoriasis	0.000238	0.00109	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—psoriasis	0.000238	0.00109	CcSEcCtD
Perphenazine—Agitation—Cyclosporine—psoriasis	0.000233	0.00107	CcSEcCtD
Perphenazine—Angioedema—Cyclosporine—psoriasis	0.000232	0.00106	CcSEcCtD
Perphenazine—Insomnia—Mycophenolic acid—psoriasis	0.000232	0.00106	CcSEcCtD
Perphenazine—Erythema—Prednisolone—psoriasis	0.000231	0.00106	CcSEcCtD
Perphenazine—Dyspnoea—Mycophenolic acid—psoriasis	0.000228	0.00105	CcSEcCtD
Perphenazine—Somnolence—Mycophenolic acid—psoriasis	0.000228	0.00104	CcSEcCtD
Perphenazine—Agitation—Mycophenolate mofetil—psoriasis	0.000228	0.00104	CcSEcCtD
Perphenazine—Leukopenia—Cyclosporine—psoriasis	0.000227	0.00104	CcSEcCtD
Perphenazine—Angioedema—Mycophenolate mofetil—psoriasis	0.000226	0.00104	CcSEcCtD
Perphenazine—Erythema—Hydrocortisone—psoriasis	0.000226	0.00104	CcSEcCtD
Perphenazine—Bradycardia—Dexamethasone—psoriasis	0.000225	0.00103	CcSEcCtD
Perphenazine—Bradycardia—Betamethasone—psoriasis	0.000225	0.00103	CcSEcCtD
Perphenazine—Hypersensitivity—Hydroxyurea—psoriasis	0.000225	0.00103	CcSEcCtD
Perphenazine—Decreased appetite—Mycophenolic acid—psoriasis	0.000223	0.00102	CcSEcCtD
Perphenazine—Syncope—Mycophenolate mofetil—psoriasis	0.000222	0.00102	CcSEcCtD
Perphenazine—Leukopenia—Mycophenolate mofetil—psoriasis	0.000222	0.00102	CcSEcCtD
Perphenazine—Cough—Cyclosporine—psoriasis	0.000222	0.00102	CcSEcCtD
Perphenazine—Convulsion—Cyclosporine—psoriasis	0.00022	0.00101	CcSEcCtD
Perphenazine—Hypertension—Cyclosporine—psoriasis	0.000219	0.00101	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—psoriasis	0.000219	0.00101	CcSEcCtD
Perphenazine—Constipation—Mycophenolic acid—psoriasis	0.000219	0.001	CcSEcCtD
Perphenazine—Pain—Mycophenolic acid—psoriasis	0.000219	0.001	CcSEcCtD
Perphenazine—Vision blurred—Prednisolone—psoriasis	0.000218	0.000999	CcSEcCtD
Perphenazine—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.000218	0.000999	CcSEcCtD
Perphenazine—Hyperglycaemia—Prednisone—psoriasis	0.000217	0.000997	CcSEcCtD
Perphenazine—Cough—Mycophenolate mofetil—psoriasis	0.000216	0.000992	CcSEcCtD
Perphenazine—Convulsion—Mycophenolate mofetil—psoriasis	0.000215	0.000984	CcSEcCtD
Perphenazine—Hypertension—Mycophenolate mofetil—psoriasis	0.000214	0.000981	CcSEcCtD
Perphenazine—Erythema—Triamcinolone—psoriasis	0.000212	0.000975	CcSEcCtD
Perphenazine—Dry mouth—Cyclosporine—psoriasis	0.000211	0.00097	CcSEcCtD
Perphenazine—Angioedema—Prednisolone—psoriasis	0.000211	0.000969	CcSEcCtD
Perphenazine—Diarrhoea—Hydroxyurea—psoriasis	0.000209	0.00096	CcSEcCtD
Perphenazine—Confusional state—Cyclosporine—psoriasis	0.000209	0.000959	CcSEcCtD
Perphenazine—Anaphylactic shock—Cyclosporine—psoriasis	0.000207	0.000951	CcSEcCtD
Perphenazine—Syncope—Prednisolone—psoriasis	0.000207	0.000951	CcSEcCtD
Perphenazine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000206	0.000946	CcSEcCtD
Perphenazine—Angioedema—Hydrocortisone—psoriasis	0.000206	0.000946	CcSEcCtD
Perphenazine—Infection—Cyclosporine—psoriasis	0.000206	0.000944	CcSEcCtD
Perphenazine—Confusional state—Mycophenolate mofetil—psoriasis	0.000204	0.000935	CcSEcCtD
Perphenazine—Loss of consciousness—Prednisolone—psoriasis	0.000203	0.000932	CcSEcCtD
Perphenazine—Body temperature increased—Mycophenolic acid—psoriasis	0.000202	0.000929	CcSEcCtD
Perphenazine—Syncope—Hydrocortisone—psoriasis	0.000202	0.000928	CcSEcCtD
Perphenazine—Dizziness—Hydroxyurea—psoriasis	0.000202	0.000928	CcSEcCtD
Perphenazine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000202	0.000927	CcSEcCtD
Perphenazine—Asthma—Methotrexate—psoriasis	0.000201	0.000924	CcSEcCtD
Perphenazine—Infection—Mycophenolate mofetil—psoriasis	0.000201	0.000921	CcSEcCtD
Perphenazine—Convulsion—Prednisolone—psoriasis	0.0002	0.000918	CcSEcCtD
Perphenazine—Hypertension—Prednisolone—psoriasis	0.000199	0.000915	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—psoriasis	0.000199	0.000915	CcSEcCtD
Perphenazine—Shock—Mycophenolate mofetil—psoriasis	0.000199	0.000912	CcSEcCtD
Perphenazine—Loss of consciousness—Hydrocortisone—psoriasis	0.000198	0.00091	CcSEcCtD
Perphenazine—Anorexia—Cyclosporine—psoriasis	0.000197	0.000906	CcSEcCtD
Perphenazine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000197	0.000905	CcSEcCtD
Perphenazine—Bradycardia—Prednisone—psoriasis	0.000196	0.000901	CcSEcCtD
Perphenazine—Convulsion—Hydrocortisone—psoriasis	0.000195	0.000897	CcSEcCtD
Perphenazine—Hypertension—Hydrocortisone—psoriasis	0.000195	0.000894	CcSEcCtD
Perphenazine—Angioedema—Triamcinolone—psoriasis	0.000194	0.000891	CcSEcCtD
Perphenazine—Erythema—Dexamethasone—psoriasis	0.000193	0.000884	CcSEcCtD
Perphenazine—Erythema—Betamethasone—psoriasis	0.000193	0.000884	CcSEcCtD
Perphenazine—Anorexia—Mycophenolate mofetil—psoriasis	0.000193	0.000884	CcSEcCtD
Perphenazine—Headache—Hydroxyurea—psoriasis	0.000192	0.000879	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—psoriasis	0.000191	0.000877	CcSEcCtD
Perphenazine—Syncope—Triamcinolone—psoriasis	0.00019	0.000874	CcSEcCtD
Perphenazine—Hypotension—Mycophenolate mofetil—psoriasis	0.000189	0.000867	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisolone—psoriasis	0.000189	0.000865	CcSEcCtD
Perphenazine—Insomnia—Cyclosporine—psoriasis	0.000187	0.00086	CcSEcCtD
Perphenazine—Loss of consciousness—Triamcinolone—psoriasis	0.000187	0.000857	CcSEcCtD
Perphenazine—Shock—Prednisolone—psoriasis	0.000185	0.000851	CcSEcCtD
Perphenazine—Cough—Triamcinolone—psoriasis	0.000185	0.000851	CcSEcCtD
Perphenazine—Dyspnoea—Cyclosporine—psoriasis	0.000185	0.000848	CcSEcCtD
Perphenazine—Somnolence—Cyclosporine—psoriasis	0.000184	0.000845	CcSEcCtD
Perphenazine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000184	0.000845	CcSEcCtD
Perphenazine—Convulsion—Triamcinolone—psoriasis	0.000184	0.000845	CcSEcCtD
Perphenazine—Tachycardia—Prednisolone—psoriasis	0.000184	0.000844	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—psoriasis	0.000184	0.000843	CcSEcCtD
Perphenazine—Hypertension—Triamcinolone—psoriasis	0.000183	0.000842	CcSEcCtD
Perphenazine—Infection—Hydrocortisone—psoriasis	0.000183	0.000839	CcSEcCtD
Perphenazine—Insomnia—Mycophenolate mofetil—psoriasis	0.000183	0.000839	CcSEcCtD
Perphenazine—Pruritus—Mycophenolic acid—psoriasis	0.000181	0.000831	CcSEcCtD
Perphenazine—Shock—Hydrocortisone—psoriasis	0.000181	0.000831	CcSEcCtD
Perphenazine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00018	0.000827	CcSEcCtD
Perphenazine—Decreased appetite—Cyclosporine—psoriasis	0.00018	0.000826	CcSEcCtD
Perphenazine—Tachycardia—Hydrocortisone—psoriasis	0.00018	0.000825	CcSEcCtD
Perphenazine—Somnolence—Mycophenolate mofetil—psoriasis	0.00018	0.000824	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—psoriasis	0.00018	0.000824	CcSEcCtD
Perphenazine—Pain—Cyclosporine—psoriasis	0.000177	0.000813	CcSEcCtD
Perphenazine—Constipation—Cyclosporine—psoriasis	0.000177	0.000813	CcSEcCtD
Perphenazine—Dry mouth—Triamcinolone—psoriasis	0.000177	0.000812	CcSEcCtD
Perphenazine—Angioedema—Dexamethasone—psoriasis	0.000176	0.000808	CcSEcCtD
Perphenazine—Angioedema—Betamethasone—psoriasis	0.000176	0.000808	CcSEcCtD
Perphenazine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000176	0.000806	CcSEcCtD
Perphenazine—Anorexia—Hydrocortisone—psoriasis	0.000176	0.000805	CcSEcCtD
Perphenazine—Diarrhoea—Mycophenolic acid—psoriasis	0.000175	0.000804	CcSEcCtD
Perphenazine—Anaphylactic shock—Triamcinolone—psoriasis	0.000173	0.000796	CcSEcCtD
Perphenazine—Syncope—Dexamethasone—psoriasis	0.000173	0.000793	CcSEcCtD
Perphenazine—Syncope—Betamethasone—psoriasis	0.000173	0.000793	CcSEcCtD
Perphenazine—Pain—Mycophenolate mofetil—psoriasis	0.000173	0.000793	CcSEcCtD
Perphenazine—Constipation—Mycophenolate mofetil—psoriasis	0.000173	0.000793	CcSEcCtD
Perphenazine—Infection—Triamcinolone—psoriasis	0.000172	0.00079	CcSEcCtD
Perphenazine—Hypotension—Hydrocortisone—psoriasis	0.000172	0.000789	CcSEcCtD
Perphenazine—Shock—Triamcinolone—psoriasis	0.000171	0.000783	CcSEcCtD
Perphenazine—Insomnia—Prednisolone—psoriasis	0.000171	0.000782	CcSEcCtD
Perphenazine—Loss of consciousness—Betamethasone—psoriasis	0.000169	0.000777	CcSEcCtD
Perphenazine—Loss of consciousness—Dexamethasone—psoriasis	0.000169	0.000777	CcSEcCtD
Perphenazine—Dizziness—Mycophenolic acid—psoriasis	0.000169	0.000777	CcSEcCtD
Perphenazine—Tachycardia—Triamcinolone—psoriasis	0.000169	0.000776	CcSEcCtD
Perphenazine—Erythema—Prednisone—psoriasis	0.000168	0.00077	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—psoriasis	0.000168	0.000769	CcSEcCtD
Perphenazine—Convulsion—Dexamethasone—psoriasis	0.000167	0.000766	CcSEcCtD
Perphenazine—Convulsion—Betamethasone—psoriasis	0.000167	0.000766	CcSEcCtD
Perphenazine—Insomnia—Hydrocortisone—psoriasis	0.000167	0.000764	CcSEcCtD
Perphenazine—Hypertension—Dexamethasone—psoriasis	0.000166	0.000764	CcSEcCtD
Perphenazine—Hypertension—Betamethasone—psoriasis	0.000166	0.000764	CcSEcCtD
Perphenazine—Urticaria—Cyclosporine—psoriasis	0.000165	0.000755	CcSEcCtD
Perphenazine—Body temperature increased—Cyclosporine—psoriasis	0.000164	0.000751	CcSEcCtD
Perphenazine—Pain—Prednisolone—psoriasis	0.000161	0.00074	CcSEcCtD
Perphenazine—Urticaria—Mycophenolate mofetil—psoriasis	0.000161	0.000737	CcSEcCtD
Perphenazine—Headache—Mycophenolic acid—psoriasis	0.00016	0.000736	CcSEcCtD
Perphenazine—Decreased appetite—Hydrocortisone—psoriasis	0.00016	0.000734	CcSEcCtD
Perphenazine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.00016	0.000733	CcSEcCtD
Perphenazine—Vision blurred—Prednisone—psoriasis	0.000158	0.000726	CcSEcCtD
Perphenazine—Pain—Hydrocortisone—psoriasis	0.000157	0.000722	CcSEcCtD
Perphenazine—Anaphylactic shock—Dexamethasone—psoriasis	0.000157	0.000722	CcSEcCtD
Perphenazine—Anaphylactic shock—Betamethasone—psoriasis	0.000157	0.000722	CcSEcCtD
Perphenazine—Insomnia—Triamcinolone—psoriasis	0.000157	0.00072	CcSEcCtD
Perphenazine—Infection—Betamethasone—psoriasis	0.000156	0.000717	CcSEcCtD
Perphenazine—Infection—Dexamethasone—psoriasis	0.000156	0.000717	CcSEcCtD
Perphenazine—Shock—Dexamethasone—psoriasis	0.000155	0.00071	CcSEcCtD
Perphenazine—Shock—Betamethasone—psoriasis	0.000155	0.00071	CcSEcCtD
Perphenazine—Dyspnoea—Triamcinolone—psoriasis	0.000155	0.000709	CcSEcCtD
Perphenazine—Agitation—Prednisone—psoriasis	0.000154	0.000708	CcSEcCtD
Perphenazine—Tachycardia—Dexamethasone—psoriasis	0.000154	0.000704	CcSEcCtD
Perphenazine—Tachycardia—Betamethasone—psoriasis	0.000154	0.000704	CcSEcCtD
Perphenazine—Angioedema—Prednisone—psoriasis	0.000153	0.000704	CcSEcCtD
Perphenazine—Hypersensitivity—Cyclosporine—psoriasis	0.000153	0.0007	CcSEcCtD
Perphenazine—Syncope—Prednisone—psoriasis	0.000151	0.000691	CcSEcCtD
Perphenazine—Anorexia—Dexamethasone—psoriasis	0.00015	0.000688	CcSEcCtD
Perphenazine—Anorexia—Betamethasone—psoriasis	0.00015	0.000688	CcSEcCtD
Perphenazine—Urticaria—Prednisolone—psoriasis	0.00015	0.000687	CcSEcCtD
Perphenazine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000149	0.000683	CcSEcCtD
Perphenazine—Pain—Triamcinolone—psoriasis	0.000148	0.00068	CcSEcCtD
Perphenazine—Loss of consciousness—Prednisone—psoriasis	0.000148	0.000677	CcSEcCtD
Perphenazine—Hypotension—Dexamethasone—psoriasis	0.000147	0.000674	CcSEcCtD
Perphenazine—Hypotension—Betamethasone—psoriasis	0.000147	0.000674	CcSEcCtD
Perphenazine—Pruritus—Cyclosporine—psoriasis	0.000147	0.000673	CcSEcCtD
Perphenazine—Urticaria—Hydrocortisone—psoriasis	0.000146	0.000671	CcSEcCtD
Perphenazine—Body temperature increased—Hydrocortisone—psoriasis	0.000146	0.000668	CcSEcCtD
Perphenazine—Convulsion—Prednisone—psoriasis	0.000145	0.000667	CcSEcCtD
Perphenazine—Hypertension—Prednisone—psoriasis	0.000145	0.000665	CcSEcCtD
Perphenazine—Pruritus—Mycophenolate mofetil—psoriasis	0.000143	0.000656	CcSEcCtD
Perphenazine—Insomnia—Dexamethasone—psoriasis	0.000142	0.000653	CcSEcCtD
Perphenazine—Insomnia—Betamethasone—psoriasis	0.000142	0.000653	CcSEcCtD
Perphenazine—Diarrhoea—Cyclosporine—psoriasis	0.000142	0.00065	CcSEcCtD
Perphenazine—Erythema—Methotrexate—psoriasis	0.00014	0.000644	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisolone—psoriasis	0.000139	0.000637	CcSEcCtD
Perphenazine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000138	0.000635	CcSEcCtD
Perphenazine—Urticaria—Triamcinolone—psoriasis	0.000138	0.000632	CcSEcCtD
Perphenazine—Body temperature increased—Triamcinolone—psoriasis	0.000137	0.000629	CcSEcCtD
Perphenazine—Dizziness—Cyclosporine—psoriasis	0.000137	0.000629	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisone—psoriasis	0.000137	0.000629	CcSEcCtD
Perphenazine—Decreased appetite—Dexamethasone—psoriasis	0.000137	0.000627	CcSEcCtD
Perphenazine—Decreased appetite—Betamethasone—psoriasis	0.000137	0.000627	CcSEcCtD
Perphenazine—Infection—Prednisone—psoriasis	0.000136	0.000624	CcSEcCtD
Perphenazine—Hypersensitivity—Hydrocortisone—psoriasis	0.000136	0.000622	CcSEcCtD
Perphenazine—Shock—Prednisone—psoriasis	0.000135	0.000618	CcSEcCtD
Perphenazine—Pain—Dexamethasone—psoriasis	0.000135	0.000617	CcSEcCtD
Perphenazine—Pain—Betamethasone—psoriasis	0.000135	0.000617	CcSEcCtD
Perphenazine—Tachycardia—Prednisone—psoriasis	0.000134	0.000614	CcSEcCtD
Perphenazine—Dizziness—Mycophenolate mofetil—psoriasis	0.000134	0.000613	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—psoriasis	0.000132	0.000607	CcSEcCtD
Perphenazine—Anorexia—Prednisone—psoriasis	0.000131	0.000599	CcSEcCtD
Perphenazine—Pruritus—Hydrocortisone—psoriasis	0.00013	0.000598	CcSEcCtD
Perphenazine—Headache—Cyclosporine—psoriasis	0.00013	0.000596	CcSEcCtD
Perphenazine—Hypersensitivity—Triamcinolone—psoriasis	0.000128	0.000586	CcSEcCtD
Perphenazine—Headache—Mycophenolate mofetil—psoriasis	0.000127	0.000581	CcSEcCtD
Perphenazine—Diarrhoea—Hydrocortisone—psoriasis	0.000126	0.000578	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—psoriasis	0.000126	0.000576	CcSEcCtD
Perphenazine—Urticaria—Dexamethasone—psoriasis	0.000125	0.000573	CcSEcCtD
Perphenazine—Urticaria—Betamethasone—psoriasis	0.000125	0.000573	CcSEcCtD
Perphenazine—Dizziness—Prednisolone—psoriasis	0.000125	0.000572	CcSEcCtD
Perphenazine—Body temperature increased—Betamethasone—psoriasis	0.000124	0.000571	CcSEcCtD
Perphenazine—Body temperature increased—Dexamethasone—psoriasis	0.000124	0.000571	CcSEcCtD
Perphenazine—Insomnia—Prednisone—psoriasis	0.000124	0.000569	CcSEcCtD
Perphenazine—Pruritus—Triamcinolone—psoriasis	0.000123	0.000563	CcSEcCtD
Perphenazine—Cough—Methotrexate—psoriasis	0.000122	0.000562	CcSEcCtD
Perphenazine—Dizziness—Hydrocortisone—psoriasis	0.000122	0.000559	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—psoriasis	0.000122	0.000558	CcSEcCtD
Perphenazine—Decreased appetite—Prednisone—psoriasis	0.000119	0.000546	CcSEcCtD
Perphenazine—Headache—Prednisolone—psoriasis	0.000118	0.000542	CcSEcCtD
Perphenazine—Constipation—Prednisone—psoriasis	0.000117	0.000538	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—psoriasis	0.000115	0.00053	CcSEcCtD
Perphenazine—Headache—Hydrocortisone—psoriasis	0.000115	0.000529	CcSEcCtD
Perphenazine—Dizziness—Triamcinolone—psoriasis	0.000115	0.000526	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—psoriasis	0.000114	0.000525	CcSEcCtD
Perphenazine—Infection—Methotrexate—psoriasis	0.000114	0.000522	CcSEcCtD
Perphenazine—Pruritus—Betamethasone—psoriasis	0.000111	0.000511	CcSEcCtD
Perphenazine—Pruritus—Dexamethasone—psoriasis	0.000111	0.000511	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—psoriasis	0.000109	0.000501	CcSEcCtD
Perphenazine—Urticaria—Prednisone—psoriasis	0.000109	0.000499	CcSEcCtD
Perphenazine—Headache—Triamcinolone—psoriasis	0.000109	0.000498	CcSEcCtD
Perphenazine—Body temperature increased—Prednisone—psoriasis	0.000108	0.000497	CcSEcCtD
Perphenazine—Diarrhoea—Dexamethasone—psoriasis	0.000108	0.000494	CcSEcCtD
Perphenazine—Diarrhoea—Betamethasone—psoriasis	0.000108	0.000494	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—psoriasis	0.000107	0.000491	CcSEcCtD
Perphenazine—Dizziness—Betamethasone—psoriasis	0.000104	0.000477	CcSEcCtD
Perphenazine—Dizziness—Dexamethasone—psoriasis	0.000104	0.000477	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—psoriasis	0.000104	0.000475	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—psoriasis	0.000102	0.000468	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—psoriasis	0.000102	0.000467	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisone—psoriasis	0.000101	0.000463	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—psoriasis	9.95e-05	0.000457	CcSEcCtD
Perphenazine—Headache—Betamethasone—psoriasis	9.85e-05	0.000452	CcSEcCtD
Perphenazine—Headache—Dexamethasone—psoriasis	9.85e-05	0.000452	CcSEcCtD
Perphenazine—Pain—Methotrexate—psoriasis	9.79e-05	0.000449	CcSEcCtD
Perphenazine—Pruritus—Prednisone—psoriasis	9.69e-05	0.000445	CcSEcCtD
Perphenazine—Diarrhoea—Prednisone—psoriasis	9.37e-05	0.00043	CcSEcCtD
Perphenazine—Urticaria—Methotrexate—psoriasis	9.1e-05	0.000417	CcSEcCtD
Perphenazine—Dizziness—Prednisone—psoriasis	9.06e-05	0.000416	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—psoriasis	9.05e-05	0.000415	CcSEcCtD
Perphenazine—Headache—Prednisone—psoriasis	8.58e-05	0.000394	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—psoriasis	8.44e-05	0.000387	CcSEcCtD
Perphenazine—Pruritus—Methotrexate—psoriasis	8.1e-05	0.000372	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—psoriasis	7.83e-05	0.000359	CcSEcCtD
Perphenazine—Dizziness—Methotrexate—psoriasis	7.57e-05	0.000347	CcSEcCtD
Perphenazine—Headache—Methotrexate—psoriasis	7.17e-05	0.000329	CcSEcCtD
Perphenazine—CALM2—Innate Immune System—NFKB1—psoriasis	1.35e-05	0.000134	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—NFKB1—psoriasis	1.35e-05	0.000134	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.34e-05	0.000133	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—NFKB1—psoriasis	1.34e-05	0.000133	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CARM1—psoriasis	1.33e-05	0.000133	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-DRB1—psoriasis	1.33e-05	0.000133	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—NFKBIA—psoriasis	1.33e-05	0.000133	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.32e-05	0.000131	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.31e-05	0.000131	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—CAT—psoriasis	1.31e-05	0.000131	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—CAT—psoriasis	1.31e-05	0.000131	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.31e-05	0.000131	CbGpPWpGaD
Perphenazine—CALM2—Disease—HLA-A—psoriasis	1.3e-05	0.00013	CbGpPWpGaD
Perphenazine—CALM1—Disease—HLA-A—psoriasis	1.3e-05	0.00013	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—NFKB1—psoriasis	1.29e-05	0.000129	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—NFKB1—psoriasis	1.29e-05	0.000129	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-DRB1—psoriasis	1.29e-05	0.000129	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-DRB1—psoriasis	1.29e-05	0.000129	CbGpPWpGaD
Perphenazine—CALM3—Immune System—ICAM1—psoriasis	1.28e-05	0.000128	CbGpPWpGaD
Perphenazine—CALM3—Immune System—NFKBIA—psoriasis	1.27e-05	0.000127	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TYK2—psoriasis	1.27e-05	0.000126	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TYK2—psoriasis	1.27e-05	0.000126	CbGpPWpGaD
Perphenazine—CALM3—Disease—APOE—psoriasis	1.26e-05	0.000126	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.25e-05	0.000125	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.25e-05	0.000124	CbGpPWpGaD
Perphenazine—CALM2—Immune System—ICAM1—psoriasis	1.24e-05	0.000124	CbGpPWpGaD
Perphenazine—CALM1—Immune System—ICAM1—psoriasis	1.24e-05	0.000124	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—LEP—psoriasis	1.23e-05	0.000123	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—APOE—psoriasis	1.23e-05	0.000123	CbGpPWpGaD
Perphenazine—CALM2—Immune System—NFKBIA—psoriasis	1.23e-05	0.000123	CbGpPWpGaD
Perphenazine—CALM1—Immune System—NFKBIA—psoriasis	1.23e-05	0.000123	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—APOE—psoriasis	1.22e-05	0.000122	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—LEP—psoriasis	1.22e-05	0.000122	CbGpPWpGaD
Perphenazine—CALM2—Disease—APOE—psoriasis	1.22e-05	0.000122	CbGpPWpGaD
Perphenazine—CALM1—Disease—APOE—psoriasis	1.22e-05	0.000122	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.21e-05	0.000121	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	1.2e-05	0.000119	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.19e-05	0.000119	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SOCS1—psoriasis	1.19e-05	0.000119	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.19e-05	0.000119	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—CAT—psoriasis	1.18e-05	0.000118	CbGpPWpGaD
Perphenazine—CALM3—Disease—NOS2—psoriasis	1.17e-05	0.000117	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—TP53—psoriasis	1.16e-05	0.000116	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SOCS1—psoriasis	1.16e-05	0.000115	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SOCS1—psoriasis	1.16e-05	0.000115	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—APOE—psoriasis	1.16e-05	0.000115	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.15e-05	0.000114	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	1.14e-05	0.000114	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—TYK2—psoriasis	1.14e-05	0.000114	CbGpPWpGaD
Perphenazine—CALM2—Disease—NOS2—psoriasis	1.13e-05	0.000113	CbGpPWpGaD
Perphenazine—CALM1—Disease—NOS2—psoriasis	1.13e-05	0.000113	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CXCL8—psoriasis	1.1e-05	0.00011	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CXCL8—psoriasis	1.1e-05	0.00011	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—TYK2—psoriasis	1.1e-05	0.00011	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—TYK2—psoriasis	1.1e-05	0.00011	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TYK2—psoriasis	1.09e-05	0.000109	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	1.09e-05	0.000108	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—APOE—psoriasis	1.08e-05	0.000108	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—APOE—psoriasis	1.08e-05	0.000108	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—LEP—psoriasis	1.08e-05	0.000108	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—LEP—psoriasis	1.06e-05	0.000106	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—APOE—psoriasis	1.06e-05	0.000106	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—TP53—psoriasis	1.06e-05	0.000106	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—LEP—psoriasis	1.06e-05	0.000106	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—APOE—psoriasis	1.06e-05	0.000106	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—APOE—psoriasis	1.05e-05	0.000105	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CAT—psoriasis	1.05e-05	0.000105	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—IL6—psoriasis	1.05e-05	0.000105	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—IL6—psoriasis	1.05e-05	0.000105	CbGpPWpGaD
Perphenazine—CALM3—Immune System—TYK2—psoriasis	1.04e-05	0.000104	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CARM1—psoriasis	1.03e-05	0.000103	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—JUN—psoriasis	1.03e-05	0.000102	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—TP53—psoriasis	1.03e-05	0.000102	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—TP53—psoriasis	1.03e-05	0.000102	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—JUN—psoriasis	1.02e-05	0.000102	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—APOE—psoriasis	1.02e-05	0.000102	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—APOE—psoriasis	1.02e-05	0.000102	CbGpPWpGaD
Perphenazine—CALM2—Immune System—TYK2—psoriasis	1.01e-05	0.0001	CbGpPWpGaD
Perphenazine—CALM1—Immune System—TYK2—psoriasis	1.01e-05	0.0001	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PPARG—psoriasis	1.01e-05	0.0001	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NFKBIA—psoriasis	1.01e-05	0.0001	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—CXCL8—psoriasis	9.91e-06	9.9e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	9.89e-06	9.87e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—NFKB1—psoriasis	9.87e-06	9.85e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NFKBIA—psoriasis	9.87e-06	9.85e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—NFKB1—psoriasis	9.86e-06	9.84e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IFNG—psoriasis	9.74e-06	9.72e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CAT—psoriasis	9.69e-06	9.67e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—LEP—psoriasis	9.66e-06	9.64e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—APOE—psoriasis	9.66e-06	9.64e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TYK2—psoriasis	9.61e-06	9.59e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CAT—psoriasis	9.6e-06	9.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—CXCL8—psoriasis	9.59e-06	9.57e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—CXCL8—psoriasis	9.59e-06	9.57e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CXCL8—psoriasis	9.5e-06	9.48e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PPARG—psoriasis	9.43e-06	9.42e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IFNG—psoriasis	9.42e-06	9.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IFNG—psoriasis	9.42e-06	9.41e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD4—psoriasis	9.41e-06	9.39e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TYK2—psoriasis	9.38e-06	9.36e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TYK2—psoriasis	9.33e-06	9.31e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TYK2—psoriasis	9.29e-06	9.27e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TYK2—psoriasis	9.29e-06	9.27e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PPARG—psoriasis	9.18e-06	9.16e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—APOE—psoriasis	9.17e-06	9.15e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD4—psoriasis	9.1e-06	9.08e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD4—psoriasis	9.1e-06	9.08e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—IL6—psoriasis	9.03e-06	9.01e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	9e-06	8.98e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—VEGFA—psoriasis	8.96e-06	8.94e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—VEGFA—psoriasis	8.95e-06	8.93e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PPARG—psoriasis	8.88e-06	8.86e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PPARG—psoriasis	8.88e-06	8.86e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—STAT3—psoriasis	8.87e-06	8.86e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—STAT3—psoriasis	8.86e-06	8.85e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—JUN—psoriasis	8.83e-06	8.81e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—LEP—psoriasis	8.81e-06	8.8e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—APOE—psoriasis	8.81e-06	8.8e-05	CbGpPWpGaD
Perphenazine—CALM3—Innate Immune System—IL6—psoriasis	8.74e-06	8.72e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—CD4—psoriasis	8.69e-06	8.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—LEP—psoriasis	8.53e-06	8.51e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—APOE—psoriasis	8.53e-06	8.51e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—LEP—psoriasis	8.53e-06	8.51e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—APOE—psoriasis	8.53e-06	8.51e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—NFKB1—psoriasis	8.5e-06	8.48e-05	CbGpPWpGaD
Perphenazine—CALM1—Innate Immune System—IL6—psoriasis	8.45e-06	8.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Innate Immune System—IL6—psoriasis	8.45e-06	8.43e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—JUN—psoriasis	8.42e-06	8.41e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—CD4—psoriasis	8.4e-06	8.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—CD4—psoriasis	8.4e-06	8.39e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TYK2—psoriasis	8.24e-06	8.22e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NFKBIA—psoriasis	8.21e-06	8.2e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CAT—psoriasis	8.21e-06	8.19e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—APOE—psoriasis	8.18e-06	8.17e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CXCL8—psoriasis	8.17e-06	8.15e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—JUN—psoriasis	8.15e-06	8.13e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—JUN—psoriasis	8.15e-06	8.13e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CXCL8—psoriasis	8.12e-06	8.11e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—NFKB1—psoriasis	8.11e-06	8.09e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TYK2—psoriasis	8.1e-06	8.09e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TYK2—psoriasis	8.09e-06	8.07e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PPARG—psoriasis	7.99e-06	7.97e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NFKBIA—psoriasis	7.94e-06	7.93e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NFKBIA—psoriasis	7.94e-06	7.93e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—NFKB1—psoriasis	7.84e-06	7.83e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—NFKB1—psoriasis	7.84e-06	7.83e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—IL6—psoriasis	7.77e-06	7.75e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—IL6—psoriasis	7.73e-06	7.71e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—VEGFA—psoriasis	7.71e-06	7.7e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—STAT3—psoriasis	7.64e-06	7.62e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—JUN—psoriasis	7.59e-06	7.58e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—JUN—psoriasis	7.55e-06	7.54e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—APOE—psoriasis	7.53e-06	7.51e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—APOE—psoriasis	7.46e-06	7.45e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TYK2—psoriasis	7.37e-06	7.36e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NFKB1—psoriasis	7.31e-06	7.29e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—STAT3—psoriasis	7.28e-06	7.27e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NFKB1—psoriasis	7.27e-06	7.26e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL8—psoriasis	7.17e-06	7.16e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PPARG—psoriasis	7.13e-06	7.11e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL8—psoriasis	7.06e-06	7.04e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—STAT3—psoriasis	7.05e-06	7.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—STAT3—psoriasis	7.05e-06	7.03e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL8—psoriasis	7.04e-06	7.03e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL6—psoriasis	6.82e-06	6.81e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—psoriasis	6.77e-06	6.76e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—psoriasis	6.76e-06	6.75e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TYK2—psoriasis	6.73e-06	6.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—STAT3—psoriasis	6.73e-06	6.71e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL6—psoriasis	6.71e-06	6.7e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL6—psoriasis	6.69e-06	6.68e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—JUN—psoriasis	6.67e-06	6.65e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—psoriasis	6.63e-06	6.62e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—psoriasis	6.6e-06	6.59e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—STAT3—psoriasis	6.57e-06	6.56e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—JUN—psoriasis	6.56e-06	6.55e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PPARG—psoriasis	6.56e-06	6.54e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—JUN—psoriasis	6.54e-06	6.53e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—STAT3—psoriasis	6.53e-06	6.52e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TYK2—psoriasis	6.51e-06	6.49e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TYK2—psoriasis	6.51e-06	6.49e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—STAT3—psoriasis	6.51e-06	6.49e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—STAT3—psoriasis	6.51e-06	6.49e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PPARG—psoriasis	6.5e-06	6.49e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL8—psoriasis	6.42e-06	6.41e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NFKB1—psoriasis	6.42e-06	6.4e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOE—psoriasis	6.38e-06	6.36e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CAT—psoriasis	6.33e-06	6.32e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NFKB1—psoriasis	6.31e-06	6.3e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NFKB1—psoriasis	6.3e-06	6.29e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—psoriasis	6.2e-06	6.19e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—psoriasis	6.19e-06	6.18e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—psoriasis	6.1e-06	6.09e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—JUN—psoriasis	5.97e-06	5.96e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—psoriasis	5.86e-06	5.85e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—psoriasis	5.83e-06	5.82e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—psoriasis	5.82e-06	5.81e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—psoriasis	5.77e-06	5.76e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NFKB1—psoriasis	5.74e-06	5.73e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—psoriasis	5.73e-06	5.72e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—psoriasis	5.72e-06	5.71e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—psoriasis	5.67e-06	5.66e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—psoriasis	5.67e-06	5.65e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—psoriasis	5.67e-06	5.65e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—psoriasis	5.66e-06	5.65e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—psoriasis	5.57e-06	5.56e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—psoriasis	5.55e-06	5.54e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—JUN—psoriasis	5.44e-06	5.43e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—psoriasis	5.39e-06	5.38e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—psoriasis	5.39e-06	5.38e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—psoriasis	5.33e-06	5.32e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—JUN—psoriasis	5.27e-06	5.26e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—JUN—psoriasis	5.27e-06	5.26e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NFKB1—psoriasis	5.24e-06	5.23e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—psoriasis	5.21e-06	5.2e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—psoriasis	5.16e-06	5.15e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—psoriasis	5.09e-06	5.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NFKB1—psoriasis	5.07e-06	5.06e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NFKB1—psoriasis	5.07e-06	5.06e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—psoriasis	5.01e-06	5e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—psoriasis	4.99e-06	4.98e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—psoriasis	4.92e-06	4.91e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—psoriasis	4.92e-06	4.91e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOE—psoriasis	4.92e-06	4.91e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—psoriasis	4.76e-06	4.75e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—psoriasis	4.71e-06	4.7e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—psoriasis	4.7e-06	4.69e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—psoriasis	4.6e-06	4.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—psoriasis	4.6e-06	4.59e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—psoriasis	4.59e-06	4.58e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—psoriasis	4.56e-06	4.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—psoriasis	4.56e-06	4.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—psoriasis	4.56e-06	4.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—psoriasis	4.54e-06	4.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—psoriasis	4.54e-06	4.54e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—psoriasis	4.4e-06	4.39e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—psoriasis	4.33e-06	4.32e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—psoriasis	4.32e-06	4.31e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—psoriasis	4.29e-06	4.28e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—psoriasis	4.03e-06	4.02e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—psoriasis	3.96e-06	3.96e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—psoriasis	3.95e-06	3.95e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—psoriasis	3.94e-06	3.93e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—psoriasis	3.61e-06	3.6e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—psoriasis	3.59e-06	3.59e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—psoriasis	3.48e-06	3.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—psoriasis	3.48e-06	3.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—psoriasis	3.29e-06	3.28e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—psoriasis	3.18e-06	3.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—psoriasis	3.18e-06	3.18e-05	CbGpPWpGaD
